Quality improvement programmes in paediatric sepsis from a global perspective

• Published in: The lancet child & adolescent health Vol. 8; no. 9; pp. 695 - 706
• Main Authors: de Souza, Daniela C, Paul, Raina, Mozun, Rebeca, Sankar, Jhuma, Jabornisky, Roberto, Lim, Emma, Harley, Amanda, Al Amri, Samirah, Aljuaid, Maha, Qian, Suyun, Schlapbach, Luregn J, Argent, Andrew, Kissoon, Niranjan
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.09.2024
• Subjects: Child; Global Health; Humans; Quality Improvement; Sepsis - therapy
• ISSN: 2352-4642; 2352-4650; 2352-4650
• DOI: 10.1016/S2352-4642(24)00142-1

Sepsis is a major contributor to poor child health outcomes around the world. The high morbidity, mortality, and societal cost associated with paediatric sepsis render it a global health priority, as summarised in Paper 1 of this Series. Sepsis is characterised by a dysregulated host response to infection that manifests as organ failure, and children are uniquely susceptible to sepsis, as discussed in Paper 2. The focus of this third Series paper is quality improvement in paediatric sepsis. The 2017 WHO resolution on sepsis outlined key aims to reduce the burden of sepsis. As of 2024, only a small number of countries have implemented systematic, paediatric-focused quality improvement programmes to raise sepsis awareness, enhance recognition of sepsis, promote timely treatment, and provide long-term support for paediatric sepsis survivors. We examine programme successes and systematic barriers to quality improvement targeting paediatric sepsis. We highlight the need for programme design to consider the entire patient journey, starting with prevention, caregiver awareness, recognition at home, education of the health-care workforce, development of health-care systems, and establishment of long-term family and survivor support extending beyond the intensive care unit. Building on lessons learnt from existing quality improvement programmes, we outline implementation strategies and measures to enable benchmarking. Ultimately, quality improvement on a global scale can only be accelerated through a global learning platform focusing on paediatric sepsis.